Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP803139.RAhbMt_6KngyH6TxMleyOaHiXNYcktf5qPg22enebuUN4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP803139.RAhbMt_6KngyH6TxMleyOaHiXNYcktf5qPg22enebuUN4130_assertion type Assertion NP803139.RAhbMt_6KngyH6TxMleyOaHiXNYcktf5qPg22enebuUN4130_head.
- NP803139.RAhbMt_6KngyH6TxMleyOaHiXNYcktf5qPg22enebuUN4130_assertion description "[Calpain-10 (CAPN10) gene was the first candidate gene of T2D identified through genome-wide linkage and positional cloning, but few works have focused on the relationship of CAPN10 with impaired fasting glucose (IFG) or impaired glucose tolerance (IGT) in EH patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP803139.RAhbMt_6KngyH6TxMleyOaHiXNYcktf5qPg22enebuUN4130_provenance.
- NP803139.RAhbMt_6KngyH6TxMleyOaHiXNYcktf5qPg22enebuUN4130_assertion evidence source_evidence_literature NP803139.RAhbMt_6KngyH6TxMleyOaHiXNYcktf5qPg22enebuUN4130_provenance.
- NP803139.RAhbMt_6KngyH6TxMleyOaHiXNYcktf5qPg22enebuUN4130_assertion SIO_000772 20406624 NP803139.RAhbMt_6KngyH6TxMleyOaHiXNYcktf5qPg22enebuUN4130_provenance.
- NP803139.RAhbMt_6KngyH6TxMleyOaHiXNYcktf5qPg22enebuUN4130_assertion wasDerivedFrom befree-20140225 NP803139.RAhbMt_6KngyH6TxMleyOaHiXNYcktf5qPg22enebuUN4130_provenance.
- NP803139.RAhbMt_6KngyH6TxMleyOaHiXNYcktf5qPg22enebuUN4130_assertion wasGeneratedBy ECO_0000203 NP803139.RAhbMt_6KngyH6TxMleyOaHiXNYcktf5qPg22enebuUN4130_provenance.